NO984093D0 - FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptider - Google Patents
FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptiderInfo
- Publication number
- NO984093D0 NO984093D0 NO984093A NO984093A NO984093D0 NO 984093 D0 NO984093 D0 NO 984093D0 NO 984093 A NO984093 A NO 984093A NO 984093 A NO984093 A NO 984093A NO 984093 D0 NO984093 D0 NO 984093D0
- Authority
- NO
- Norway
- Prior art keywords
- prosaposin
- neuropathic pain
- methods
- derived peptides
- relieving neuropathic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/611,307 US6271196B1 (en) | 1996-03-05 | 1996-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
PCT/US1997/004143 WO1997032895A1 (en) | 1996-03-05 | 1997-03-05 | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984093D0 true NO984093D0 (no) | 1998-09-04 |
NO984093L NO984093L (no) | 1998-11-04 |
Family
ID=24448513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984093A NO984093L (no) | 1996-03-05 | 1998-09-04 | FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider |
Country Status (16)
Country | Link |
---|---|
US (2) | US6271196B1 (no) |
EP (1) | EP0929569B1 (no) |
JP (1) | JP4138006B2 (no) |
KR (1) | KR100507715B1 (no) |
AT (1) | ATE340187T1 (no) |
AU (1) | AU734566B2 (no) |
CA (1) | CA2248139C (no) |
CZ (1) | CZ297384B6 (no) |
DE (1) | DE69736712T2 (no) |
IL (1) | IL126082A0 (no) |
NO (1) | NO984093L (no) |
NZ (1) | NZ331757A (no) |
PL (1) | PL187917B1 (no) |
RU (2) | RU2223969C2 (no) |
SK (1) | SK122898A3 (no) |
WO (1) | WO1997032895A1 (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571787A (en) * | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
US6849602B1 (en) * | 1996-03-05 | 2005-02-01 | The Regents Of The University Of California | Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
JP2001524944A (ja) * | 1997-03-05 | 2001-12-04 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 神経障害性疼痛の緩和方法 |
CA2282827A1 (en) * | 1997-03-05 | 1998-09-11 | The Regents Of The University Of California | Method of alleviating neuropathic pain |
CA2284105A1 (en) * | 1997-03-24 | 1998-10-01 | John S. O'brien | Synthetic saposin c-derived neurotrophic peptides |
US6458357B1 (en) * | 1997-09-09 | 2002-10-01 | Myelos Corporation | Retro-inverso neurotrophic and analgesic peptides |
JP2001515866A (ja) * | 1997-09-09 | 2001-09-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | プロサポシン受容体アゴニストを利用したアポトーシスの阻害 |
CZ2001655A3 (cs) * | 1998-08-28 | 2001-11-14 | Myelos Corporation | Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby |
US20020028783A1 (en) * | 1999-09-09 | 2002-03-07 | O'brien John S. | Method of stimulating prosaposin receptor activity |
USRE45976E1 (en) * | 1999-02-24 | 2016-04-19 | Tact Ip, Llc | Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally |
EP1165611A1 (en) * | 1999-03-30 | 2002-01-02 | Myelos Corporation | Retro-inverso prosaposin-derived peptides and use thereof |
US7410941B1 (en) | 1999-04-13 | 2008-08-12 | The Kenneth S. Warren Institute, Inc. | Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin |
US7345019B1 (en) | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
CA2376474A1 (en) * | 1999-06-16 | 2000-12-21 | David E. Wright | Retro-inverso peptides derived from leukemia inhibitory factor |
CA2376479A1 (en) * | 1999-06-16 | 2000-12-21 | David E. Wright | Retro-inverso peptides derived from interleukin-6 |
US7109168B1 (en) | 2000-06-16 | 2006-09-19 | Myelos Corporation | Retro-inverso peptides derived from leukemia inhibitory factor |
JP2003502340A (ja) * | 1999-06-16 | 2003-01-21 | マイアロス コーポレイション | インターロイキン−3から誘導されるレトロ−インベルソペプチド |
US7135461B1 (en) | 2000-06-16 | 2006-11-14 | Myelos Corporation | Retro-inverso peptides derived from interleukin-6 |
US7420030B2 (en) * | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US20050074747A1 (en) * | 2000-09-08 | 2005-04-07 | Wadih Arap | Biopanning and rapid analysis of selective interactive ligands (brasil) |
US20040170955A1 (en) | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
US6531121B2 (en) | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
US20060287240A1 (en) * | 2001-03-09 | 2006-12-21 | O'brien John S | Method of stimulating prosaposin receptor activity |
EP1418932A4 (en) * | 2001-07-18 | 2006-03-15 | Univ Texas | ANTI-ANGIOGENIC STATE IN MOUSE AND HUMAN BEINGS SUFFERING FROM CELL DEGENERATION OF THE RETINAL PHOTORECEPTOR |
US20040048243A1 (en) * | 2001-09-07 | 2004-03-11 | Wadih Arap | Methods and compositions for in vitro targeting |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US20040096089A1 (en) * | 2002-08-16 | 2004-05-20 | David Borsook | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
US7166691B2 (en) * | 2002-12-20 | 2007-01-23 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Saposin C and receptors as targets for treatment of benign and malignant disorders |
EP1605965B1 (en) * | 2003-03-26 | 2012-12-26 | DeveloGen Aktiengesellschaft | Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
NZ542690A (en) * | 2003-03-28 | 2009-04-30 | Acadia Pharm Inc | Muscarinic M1 receptor agonists for pain management |
US7834147B2 (en) * | 2003-04-28 | 2010-11-16 | Childrens Hospital Medical Center | Saposin C-DOPS: a novel anti-tumor agent |
CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
US9345745B2 (en) * | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
US7964585B2 (en) * | 2006-03-14 | 2011-06-21 | Case Western Reserve University | Composition and method of treating peripheral neuropathy |
CN108743916A (zh) | 2008-01-22 | 2018-11-06 | 阿拉伊姆药品公司 | 用于预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物 |
RU2561582C2 (ru) * | 2010-11-19 | 2015-08-27 | Российская Федерация в лице Министерства промышленности и торговли Российской Федерации | Инъекционная лекарственная форма олигопептидного препарата для лечения рассеянного склероза и способ ее получения |
JP5971729B2 (ja) * | 2011-02-23 | 2016-08-17 | 北海道公立大学法人 札幌医科大学 | 疼痛を治療、改善、または予防するための組成物 |
RU2669692C1 (ru) * | 2017-08-14 | 2018-10-15 | Павел Андреевич Канаев | Способ получения комплекса биологически активных пептидов обладающих нейротропной активностью |
PL3768246T3 (pl) * | 2018-03-23 | 2022-01-03 | Bexion Pharmaceuticals, Inc. | Kompozycje farmaceutyczne sapozyny c i ich zastosowanie w leczeniu nowotworu |
CN111936508A (zh) | 2018-03-29 | 2020-11-13 | 横向知识产权私人有限公司 | 环肽及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE108459T1 (de) | 1986-04-22 | 1994-07-15 | Salk Inst For Biological Studi | Antagonisten des fibroblasten-wachstumsfaktors. |
US5470582A (en) | 1992-02-07 | 1995-11-28 | Syntex (U.S.A.) Inc. | Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles |
US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
US5700909A (en) * | 1993-07-30 | 1997-12-23 | The Regents Of The University Of California | Prosaposin and cytokine-derived peptides |
CA2282827A1 (en) * | 1997-03-05 | 1998-09-11 | The Regents Of The University Of California | Method of alleviating neuropathic pain |
CA2284105A1 (en) * | 1997-03-24 | 1998-10-01 | John S. O'brien | Synthetic saposin c-derived neurotrophic peptides |
-
1996
- 1996-03-05 US US08/611,307 patent/US6271196B1/en not_active Expired - Fee Related
-
1997
- 1997-03-05 KR KR1019980707151A patent/KR100507715B1/ko not_active IP Right Cessation
- 1997-03-05 CZ CZ0283998A patent/CZ297384B6/cs not_active IP Right Cessation
- 1997-03-05 SK SK1228-98A patent/SK122898A3/sk unknown
- 1997-03-05 NZ NZ331757A patent/NZ331757A/en active IP Right Revival
- 1997-03-05 RU RU98118091/04A patent/RU2223969C2/ru not_active IP Right Cessation
- 1997-03-05 AT AT97916005T patent/ATE340187T1/de not_active IP Right Cessation
- 1997-03-05 DE DE69736712T patent/DE69736712T2/de not_active Expired - Fee Related
- 1997-03-05 WO PCT/US1997/004143 patent/WO1997032895A1/en active IP Right Grant
- 1997-03-05 AU AU23286/97A patent/AU734566B2/en not_active Ceased
- 1997-03-05 CA CA002248139A patent/CA2248139C/en not_active Expired - Fee Related
- 1997-03-05 EP EP97916005A patent/EP0929569B1/en not_active Expired - Lifetime
- 1997-03-05 IL IL12608297A patent/IL126082A0/xx unknown
- 1997-03-05 PL PL32870197A patent/PL187917B1/pl not_active IP Right Cessation
- 1997-03-05 JP JP53205097A patent/JP4138006B2/ja not_active Expired - Fee Related
- 1997-03-05 RU RU2003131695/14A patent/RU2266129C2/ru not_active IP Right Cessation
-
1998
- 1998-09-04 NO NO984093A patent/NO984093L/no not_active Application Discontinuation
-
1999
- 1999-01-15 US US09/231,159 patent/US6268347B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2223969C2 (ru) | 2004-02-20 |
AU734566B2 (en) | 2001-06-14 |
NZ331757A (en) | 1999-10-28 |
AU2328697A (en) | 1997-09-22 |
RU2003131695A (ru) | 2005-04-10 |
DE69736712D1 (de) | 2006-11-02 |
EP0929569A1 (en) | 1999-07-21 |
CZ297384B6 (cs) | 2006-11-15 |
CA2248139C (en) | 2004-05-18 |
EP0929569A4 (en) | 2000-08-23 |
PL187917B1 (pl) | 2004-11-30 |
RU2266129C2 (ru) | 2005-12-20 |
CA2248139A1 (en) | 1997-09-12 |
JP4138006B2 (ja) | 2008-08-20 |
US6268347B1 (en) | 2001-07-31 |
SK122898A3 (en) | 2000-02-14 |
ATE340187T1 (de) | 2006-10-15 |
EP0929569B1 (en) | 2006-09-20 |
JP2000506853A (ja) | 2000-06-06 |
PL328701A1 (en) | 1999-02-15 |
IL126082A0 (en) | 1999-05-09 |
NO984093L (no) | 1998-11-04 |
US6271196B1 (en) | 2001-08-07 |
WO1997032895A1 (en) | 1997-09-12 |
KR19990087686A (ko) | 1999-12-27 |
DE69736712T2 (de) | 2007-09-13 |
KR100507715B1 (ko) | 2006-05-26 |
CZ283998A3 (cs) | 1999-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984093L (no) | FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider | |
AU7321598A (en) | Use of cholinesterase inhibitors to treat disorders of attention | |
EP0831832A4 (en) | METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES | |
DK0867178T3 (da) | Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser | |
AU9021298A (en) | Agmatine as a treatment for neuropathic pain | |
EA200000239A1 (ru) | Стимуляторы секреции гормона роста | |
EP0813544A4 (no) | ||
AU5323396A (en) | Methods of treating inflammation and compositions therefor | |
EA199800866A1 (ru) | Способ снятия боли | |
AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
WO1999065475A3 (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
ATE270113T1 (de) | Zusammenstellungen zur verbesserten wundheilung | |
IL139303A0 (en) | Treatment of arthritis and other similar conditions | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
AU5434899A (en) | Cancer treatment | |
NO984198D0 (no) | Fremgangsmåte for behandling av aggresjon | |
IL126158A0 (en) | Method for treating substance abuse | |
NO984190L (no) | FremgangsmÕte for behandling av insomnia | |
AU4390597A (en) | Combination therapy for treatment of arthritic diseases | |
NO985325L (no) | Anvendelse av substituert azaspiran ved behandling av astma | |
NO965029D0 (no) | Cellulære faktorer som regulerer ekspresjon av gener som koder for proteiner involvert i kolesterolhomeostase | |
UA32108A (uk) | Спосіб лікування хронічного тонзиліту | |
UA43389C2 (uk) | Спосіб зниження рівнів кальцію у сироватці |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |